Proto Script Pharmaceutical Corp. (PSCR)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: May 12, 2025

PSCR Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2016 FY 2015 FY 2014
Period Ending
Sep '17 Dec '16 Dec '15 Dec '14
Net Income
-8.39-7.18-0.15-0.24
Depreciation & Amortization
0.010.010.080.09
Provision & Write-off of Bad Debts
-0.01-0.020.05-
Other Operating Activities
7.16.88--
Change in Accounts Receivable
0.090.050.09-0.08
Change in Accounts Payable
0.140.13-0.03-0.02
Change in Other Net Operating Assets
0.460.18-0-0
Operating Cash Flow
-0.30.040.04-0.12
Operating Cash Flow Growth
-15.84%--
Capital Expenditures
-0.03-0.02-0.01-0
Sale (Purchase) of Intangibles
----0.01
Investing Cash Flow
-0.03-0.02-0.01-0.01
Short-Term Debt Issued
-0.030.040.07
Total Debt Issued
0.330.030.040.07
Net Debt Issued (Repaid)
0.330.030.040.07
Other Financing Activities
--0.06-0.090.01
Financing Cash Flow
0.33-0.03-0.050.07
Net Cash Flow
-0.01-0.01-0.02-0.06
Free Cash Flow
-0.340.030.03-0.12
Free Cash Flow Growth
--9.78%--
Free Cash Flow Margin
-55.69%3.66%3.63%-13.11%
Free Cash Flow Per Share
-0.00---0.12
Levered Free Cash Flow
0.410.170.11-
Unlevered Free Cash Flow
0.520.170.11-
Change in Net Working Capital
-1.16-0.37-0.13-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.